An Evaluation Of BW430C (Lamotrigine) Versus Placebo In The Prevention Of Mood Episodes In Bipolar I Disorder Patients

Clinical trial NCT00550407 · COMPLETED

Trial details

NCT number: NCT00550407
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Bipolar Disorder

Start date: 2007-11-01
Primary completion: 2009-10-01
Enrollment: 215

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.